The role of ketamine in pain management

Biomedicine and Pharmacotherapy

Volumn 60, Issue 7, 2006, Pages 341-348

  Visser, E ^a   Schug, S A ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Analgesia; Antagonist; Ketamine; NMDA receptor; Pain

Indexed keywords

AMITRIPTYLINE; ANESTHETIC AGENT; BENZODIAZEPINE; FENTANYL; GLYCERYL TRINITRATE; KETAMINE; LIDOCAINE; MIDAZOLAM; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; OPIATE; PROPOFOL; REMIFENTANIL; ANALGESIC AGENT;

ABDOMINAL PAIN; AGING; AGNOSIA; ALLODYNIA; ANALGESIA; ANALGESIC AGENT ABUSE; ANGINA PECTORIS; ANOREXIA; ARTICLE; BREAST FEEDING; CANCER PAIN; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPLEX REGIONAL PAIN SYNDROME; DROWSINESS; DRUG MECHANISM; DRUG MEGADOSE; DRUG SAFETY; DYSPHORIA; FACE PAIN; HALLUCINATION; HUMAN; HYPERALGESIA; KIDNEY DISEASE; LEG PAIN; LIVER DISEASE; LIVER FAILURE; LOW DRUG DOSE; MEMORY DISORDER; META ANALYSIS; MIGRAINE; NAUSEA AND VOMITING; NECK PAIN; NERVE BLOCK; NEUROPATHIC PAIN; NEUROTOXICITY; NIGHTMARE; PAIN; PATIENT CONTROLLED ANALGESIA; POSTOPERATIVE PAIN; PREGNANCY; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SEDATION; SIDE EFFECT; SLEEP DISORDER; SYSTEMATIC REVIEW; TRIGEMINUS NEURALGIA; VISCERAL PAIN; VISUAL ANALOG SCALE; VISUAL DISORDER; CHRONIC DISEASE; NEOPLASM; REVIEW;

ANALGESICS; CHRONIC DISEASE; HUMANS; KETAMINE; NEOPLASMS; PAIN;

EID: 33748134772     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.06.021     Document Type: Article

References (101)

1. Reich D.L., and Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can. J. Anaesth. 36 2 (1989) 186-197
2. Paix B.R., Capps R., Neumeister G., and Semple T. Anaesthesia in a disaster zone: a report on the experience of an Australian medical team in Banda Aceh following the 'Boxing Day Tsunami'. Anaesth. Intensive Care 33 5 (2005) 629-634
3. White P.F., Way W.L., and Trevor A.J. Ketamine-its pharmacology and therapeutic uses. Anesthesiology 56 2 (1982) 119-136
4. Elia N., and Tramer M.R. Ketamine and postoperative pain-a quantitative systematic review of randomised trials. Pain 113 1-2 (2005) 61-70
5. Bell R.F., Dahl J.B., Moore R.A., and Kalso E. Perioperative ketamine for acute postoperative pain. Cochrane Database Syst. Rev. 1 (2006) (CD004603)
6. Bell R.F., Dahl J.B., Moore R.A., and Kalso E. Peri-operative ketamine for acute post-operative pain: a quantitative and qualitative systematic review (Cochrane review). Acta Anaesthesiol. Scand. 49 10 (2005) 1405-1428
7. Subramaniam K., Subramaniam B., and Steinbrook R.A. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth. Analg. 99 2 (2004) 482-495
8. Adam F., Chauvin M., Du Manoir B., Langlois M., Sessler D.I., and Fletcher D. Small-dose ketamine infusion improves postoperative analgesia and rehabilitation after total knee arthroplasty. Anesth. Analg. 100 2 (2005) 475-480
9. Argiriadou H., Himmelseher S., Papagiannopoulou P., Georgiou M., Kanakoudis F., Giala M., et al. Improvement of pain treatment after major abdominal surgery by intravenous S+-ketamine. Anesth. Analg. 98 5 (2004) 1413-1418
10. Becke K., Albrecht S., Schmitz B., Rech D., Koppert W., Schlutter J., et al. Intraoperative low-dose S-ketamine has no preventive effects on postoperative pain and morphine consumption after major urological surgery in children. Paediatr. Anaesth. 15 6 (2005) 484-490
11. Ganne O., Abisseror M., Menault P., Malhiere S., Ganne L., Chambost V., et al. Low-dose ketamine failed to spare morphine after a remifentanil-based anaesthesia for ear, nose and throat surgery. Eur. J. Anaesthesiol. 22 6 (2005) 426-430
12. Gurnani A., Sharma P.K., Rautela R.S., and Battacharya B. Analgesia for acute musculoskeletal trauma: low-dose subcutaneous infusion of ketamine. Anaesth. Intensive Care 24 1 (1996) 32-36
13. Weinbroum A.A. A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain. Anesth. Analg. 96 3 (2003) 789-795
14. Bell R.F. Low-dose subcutaneous ketamine infusion and morphine tolerance. Pain 83 1 (1999) 101-103
15. Eilers H., Philip L.A., Bickler P.E., McKay W.R., and Schumacher M.A. The reversal of fentanyl-induced tolerance by administration of "small-dose" ketamine. Anesth. Analg. 93 1 (2001) 213-214
16. Joly V., Richebe P., Guignard B., Fletcher D., Maurelle P., Sessler D.I., et al. Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 103 1 (2005) 147-155
17. Stubhaug A., Breivik H., Eide P.K., Kreunen M., and Foss A. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery. Acta Anaesthesiol. Scand. 41 9 (1997) 1124-1132
18. De Kock M., Lavand'homme P., and Waterloos H. 'Balanced analgesia' in the perioperative period: is there a place for ketamine?. Pain 92 3 (2001) 373-380
19. McCartney C.J., Sinha A., and Katz J. A qualitative systematic review of the role of N-methyl-d-aspartate receptor antagonists in preventive analgesia. Anesth. Analg. 98 5 (2004) 1385-1400
20. Ong C.K., Lirk P., Seymour R.A., and Jenkins B.J. The efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysis. Anesth. Analg. 100 3 (2005) 757-773
21. Nishimoto C., Yamaguchi H., Sato S., and Toyooka H. Preoperative ketamine prevented chronic pain after breast surgery in female patients. Anesthesiology 89 3A (1998) A1146
22. Chow T.K.F., Goodchild C.S., Shanahan E.A., O'Flaherty M., and McNeil J.J. Adding ketamine to morphine reduces acute and chronic post-thoractomy pain. Anaesth Intens Care 30 5 (2002) 692-693
23. Katz J., Schmid R., Snijdelaar D.G., Coderre T.J., McCartney C.J., and Wowk A. Pre-emptive analgesia using intravenous fentanyl plus low-dose ketamine for radical prostatectomy under general anesthesia does not produce short-term or long-term reductions in pain or analgesic use. Pain 110 3 (2004) 707-718
24. Dertwinkel R., Heinrichs C., Senne I., Tegenthoff M., Weiss T., Malin J.P., et al. Prevention of severe phantom limb pain by perioperative administration of ketamine-an observational study. Acute Pain 4 1 (2002) 12-16
25. Hayes C., Armstrong-Brown A., and Burstal R. Perioperative intravenous ketamine infusion for the prevention of persistent post-amputation pain: a randomized, controlled trial. Anaesth. Intensive Care 32 3 (2004) 330-338
26. Azevedo V.M., Lauretti G.R., Pereira N.L., and Reis M.P. Transdermal ketamine as an adjuvant for postoperative analgesia after abdominal gynecological surgery using lidocaine epidural blockade. Anesth. Analg. 91 6 (2000) 1479-1482
27. Murat I., Gall O., and Tourniaire B. Procedural pain in children: evidence-based best practice and guidelines. Reg. Anesth. Pain Med. 28 6 (2003) 561-572
28. Migita R.T., Klein E.J., and Garrison M.M. Sedation and analgesia for pediatric fracture reduction in the emergency department: a systematic review. Arch. Pediatr. Adolesc. Med. 160 1 (2006) 46-51
29. Schmid R.L., Sandler A.N., and Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: a review of current techniques and outcomes. Pain 82 2 (1999) 111-125
30. Malinovsky J.-M., Lepage J.-Y., Cozian A., Mussim J.-M., Pinaudt M., and Souron R. Is ketamine or its preservative responsible for neurotoxicity in the rabbit?. Anesthesiology 78 (1993) 109-115
31. Hodgson P.S., Neal J.M., Pollock J.E., and Liu S.S. The neurotoxicity of drugs given intrathecally (spinal). Anesth. Analg. 88 4 (1999) 797-809
32. Ansermino M., Basu R., Vandebeek C., and Montgomery C. Nonopioid additives to local anaesthetics for caudal blockade in children: a systematic review. Paediatr. Anaesth. 13 7 (2003) 561-573
33. Kathirvel S., Sadhasivam S., Saxena A., Kannan T., and Ganjoo P. Effects of intrathecal ketamine added to bupivacaine for spinal anaesthesia. Anaesthesia 55 (2000) 899-904
34. Zohar E., Luban I., Zunser I., Shapiro A., Jedei Kin R., and Fredman B. Patient-controlled bupivacaine wound instillation following cesarean section: the lack of efficacy of adjuvant ketamine. J. Clin. Anesth. 14 7 (2002) 505-511
35. Lee I.O., Kim W.K., Kong M.H., Lee M.K., Kim N.S., Choi Y.S., et al. No enhancement of sensory and motor blockade by ketamine added to ropivacaine interscalene brachial plexus blockade. Acta Anaesthesiol. Scand. 46 7 (2002) 821-826
36. Rosseland L.A., Stubhaug A., Sandberg L., and Breikk H. Intra-articular (IA) catheter administration of postoperative analgesics. A new trial design allows evaluation of baseline pain, demonstrates large variation in need of analgesics, and finds no analgesic effect of IA ketamine compared with IA saline. Pain 104 1-2 (2003) 25-34
37. Clerc S., Vuilleumier H., Frascarolo P., Spahn D.R., and Gardaz J.P. Is the effect of inguinal field block with 0.5% bupivacaine on postoperative pain after hernia repair enhanced by addition of ketorolac or S(+) ketamine?. Clin. J. Pain 21 1 (2005) 101-105
38. Colleau S. Essential adjuvant analgesics for neuropathic pain. In: Colleau S. (Ed). Cancer pain release (2002)
39. Bell R., Eccleston C., and Kalso E. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst. Rev. 1 (2003) (CD003351)
40. Bell R.F., Eccleston C., and Kalso E. Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review. J. Pain Symptom Manage. 26 3 (2003) 867-875
41. Jackson K., Ashby M., and Goodchild C. Subanesthetic ketamine for cancer pain: by insisting on level I/II evidence, do we risk throwing the baby out with the bath water?. J. Pain Symptom Manage. 29 4 (2005) 328-330
42. Mercadante S., Arcuri E., Tirelli W., and Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J. Pain Symptom Manage. 20 4 (2000) 246-252
43. Fitzgibbon E.J., and Viola R. Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit. J. Palliat. Med. 8 1 (2005) 49-57
44. Lossignol D.A., Obiols-Portis M., and Body J.J. Successful use of ketamine for intractable cancer pain. Support. Care Cancer 13 3 (2005) 188-193
45. Kotlinska-Lemieszek A., and Luczak J. Subanesthetic ketamine: an essential adjuvant for intractable cancer pain. J. Pain Symptom Manage. 28 2 (2004) 100-102
46. Jackson K., Ashby M., Martin P., Pisasale M., Brumley D., and Hayes B. "Burst" ketamine for refractory cancer pain: an open label audit of 39 patients. J. Pain Symptom Manage. 22 4 (2001) 834-842
47. Mitchell A.C. Generalized hyperalgesia and allodynia following abrupt cessation of subcutaneous ketamine infusion. Palliat. Med. 13 5 (1999) 427-428
48. Mercadante S., Arcuri E., Ferrera P., Villari P., and Mangiones S. Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J. Pain Symptom Manage. 30 5 (2005) 485-491
49. Lauretti G.R., Lima I.C., Reis M.P., Prado W.A., and Periera N.L. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology 90 6 (1999) 1528-1533
50. Kannan T.R., Saxena A., Bhatnagar S., and Barry A. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients. J. Pain Symptom Manage. 23 1 (2002) 60-65
51. Yang C.Y., Wong C.S., Chang J.Y., and Ho St. Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can. J. Anaesth. 43 4 (1996) 379-383
52. Vranken J.H., van der Vegt M.H., Kal J.E., and Kruis M.R. Treatment of neuropathic cancer pain with continuous intrathecal administration of S+-ketamine. Acta Anaesthesiol. Scand. 48 2 (2004) 249-252
53. Benrath J., Scharbert G., Gustorff B., Adams H.A., and Kress H.G. Long-term intrathecal S(+)-ketamine in a patient with cancer-related neuropathic pain. Br. J. Anaesth. 95 2 (2005) 247-249
54. In: Merskey H., and Bogduk N. (Eds). Classification of chronic pain. 2nd ed (1994), IASP Press, Seattle
55. Siddall P.J., and Cousins M.J. Persistent pain as a disease entity: implications for clinical management. Anesth. Analg. 99 2 (2004) 510-520
56. Hocking G., and Cousins M.J. Ketamine in chronic pain management: an evidence-based review. Anesth. Analg. 97 6 (2003) 1730-1739
57. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 3 (2005) 289-305
58. Kvarnstrom A., Karlsten R., Quiding H., Emanuelsson B.M., and Gordh I. The effectiveness of intravenous ketamine and lidocaine on peripheral neuropathic pain. Acta Anaesthesiol. Scand. 47 7 (2003) 868-877
59. Max M.B., Byas-Smith M.G., Gracely R.H., and Bennet G.J. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin. Neuropharmacol. 18 4 (1995) 360-368
60. Haines D.R., and Gaines S.P. N of 1 randomised controlled trials of oral ketamine in patients with chronic pain. Pain 83 2 (1999) 283-287
61. Enarson M.C., Hays H., and Woodroffe M.A. Clinical experience with oral ketamine. J. Pain Symptom Manage. 17 5 (1999) 384-386
62. Hempenstall K., Nurmikko T.J., Johnson R.W., A' Hern R.P., and Rice A.S. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2 7 (2005) e164
63. Eide P.K., Jorum E., Stubhaug A., et al. Relief of post-herpetic neuralgia with the N-methyl-d-aspartate receptor antagonist ketamine: a double blind, cross-over comparison with morphine and placebo. Pain 58 (1994) 347-354
64. Eide P.K., Stubhaug A., Oye I., and Breivik H. Continuous subcutaneous administration of the N-methyl-d-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain 61 2 (1995) 221-228
65. Eide P.K., Stubhaug A., and Stenehjem A.E. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-d-aspartate receptor activation. Neurosurgery 37 6 (1995) 1080-1087
66. Kvarnstrom A., Karlsten R., Quiding H., and Gordh T. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury. Acta Anaesthesiol. Scand. 48 4 (2004) 498-506
67. Vranken J.H., Dijkgraaf M.G., Kruis M.R., van Dasselaar N.T., and van der Vegt M.H. Iontophoretic administration of S(+)-ketamine in patients with intractable central pain: a placebo-controlled trial. Pain 118 1-2 (2005) 224-231
68. Sakai T., Tomiyasu S., Ono T., Yamada H., and Sumikawa K. Multiple sclerosis with severe pain and allodynia alleviated by oral ketamine. Clin. J. Pain 20 5 (2004) 375-376
69. Parisod E. Management of pain in a patient with Guillain-Barre syndrome. ANZCA Bulletin 11 3 (2002) 53-60
70. Eide P.K., and Stubhaug A. Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade. Neurosurgery 41 2 (1997) 505-508
71. Rabben T., and Oye I. Interindividual differences in the analgesic response to ketamine in chronic orofacial pain. Eur. J. Pain 5 3 (2001) 233-240
72. Lynch M.E., Clark A.J., Sawynok J., and Sullivan M.J. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J. Pain 6 10 (2005) 644-649
73. Lynch M.E., Clark A.J., Sawynok J., and Sullivan M.J. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology 103 1 (2005) 140-146
74. Correll G.E., Maleki J., Gracely E.J., Muir J.J., and Harbut R.E. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med. 5 3 (2004) 263-275
75. Ushida T., Tani T., Kanbara T., Zinckuk V.S., Kawasaki M., and Yamamoto H. Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1. Reg. Anesth. Pain Med. 27 5 (2002) 524-528
76. Nikolajsen L., Hansen C.L., Nielsen J., Keller J., Arendt-Nielsen L., and Jensen T.S. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 67 1 (1996) 69-77
77. Stannard C.F., and Porter G.E. Ketamine hydrochoride in the treatment of phantom limb pain. Pain 54 (1993) 227-230
78. Nikolajsen L., Hansen P.O., and Jensen T.S. Oral ketamine therapy in the treatment of postamputation stump pain. Acta Anaesthesiol. Scand. 41 3 (1997) 427-429
79. Persson J., Hasselstrom J., Wiklund B., Heller A., Svenssen J.O., and Gustafsson L.L. The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans. Acta Anaesthesiol. Scand. 42 7 (1998) 750-758
80. Sorensen J., Bengtsson A., Backman E., Henriksson K.G., and Bengtsson M. Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine. Scand. J. Rheumatol. 24 6 (1995) 360-365
81. Graven-Nielsen T., Aspegren Kendall S., Henriksson K.G., Bengtsson M., Sorensen J., Johnson A., et al. Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85 3 (2000) 483-491
82. Strigo I.A., Duncan G.H., Bushnell M.C., Boivin M., Wainer I., Rodriguez Rosas M.G., et al. The effects of racemic ketamine on painful stimulation of skin and viscera in human subjects. Pain 113 3 (2005) 255-264
83. Willert R.P., Woolf C.J., Hobson A.R., et al. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-d-aspartate receptor. Gastroenterology 126 3 (2004) 683-692
84. Kuiken S.D., van den Berg S.J., Tytgat G.N., and Bœchxæstaens G.E. Oral S(+)-ketamine does not change visceral perception in health. Dig. Dis. Sci. 49 11-12 (2004) 1745-1751
85. Mannion S., and O'Brien T. Ketamine in the management of chronic pancreatic pain. J. Pain Symptom Manage. 26 6 (2003) 1071-1072
86. Lemming D., Sorensen J., Graven-Nielsen T., Arendt-Nielsen L., and Gerdle B. The responses to pharmacological challenges and experimental pain in patients with chronic whiplash-associated pain. Clin. J. Pain 21 5 (2005) 412-421
87. Sator-Katzenschlager S., Deusch E., Maier P., Spacek A., and Kress H.G. The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance. Anesth. Analg. 93 4 (2001) 1032-1034
88. Carr D.B., Goudas L.C., Denman W.T., Brokoff D., Staats P.S., Brennen L., et al. Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study. Pain 108 1-2 (2004) 17-27
89. Nicolodi M., and Sicuteri F. Exploration of NMDA receptors in migraine: therapeutic and theoretic implications. Int. J. Clin. Pharmacol. Res. 15 5-6 (1995) 181-189
90. Kaube H., Herzog J., Kaufer T., Dichgans M., and Diener H.C. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 55 1 (2000) 139-141
91. Narendran R., Frankle W.G., Keefe R., Gil R., Martinez D., Slifstein M., et al. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am. J. Psychiatry 162 12 (2005) 2352-2359
92. Malhotra A.K., Pinals D.A., Weingartner H., Sirocco K., Missor C.D., Pokar D., et al. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14 5 (1996) 301-307
93. Curran H.V., and Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction 95 4 (2000) 575-590
94. Morgan C.J., Rossell S.L., Pepper F., Smart J., Blackburn J., Brandner B., et al. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users. Biol. Psychiatry 59 3 (2006) 265-272
95. Curran H.V., and Monaghan L. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 96 5 (2001) 749-760
96. Schonenberg M., Reichwald U., Domes G., Badke A., and Hautzinger M. Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims. Psychopharmacology (Berl.) 182 3 (2005) 420-425
97. Pal H.R., Berry N., Kumar R., and Ray R. Ketamine dependence. Anaesth. Intensive Care 30 3 (2002) 382-384
98. Degenhardt L., Copeland J., and Dillon P. Recent trends in the use of "club drugs": an Australian review. Subst. Use Misuse 40 9-10 (2005) 1241-1256
99. Carr D.B., Goudas L.C., Denman W.T., Brokoff D., Lavin P.T., and Staats P.S. Safety and efficacy of intranasal ketamine in a mixed population with chronic pain. Pain 110 3 (2004) 762-764
100. Murphy E.J. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth. Intensive Care 33 3 (2005) 311-322
101. Australian and New Zealand College of Anaesthetists. Faculty of Pain Medicine. Acute pain management: scientific evidence. 2nd ed (2005), Australian and New Zealand College of Anaesthetists, Melbourne